Genmab
GMAB
GMAB
216 hedge funds and large institutions have $1.33B invested in Genmab in 2025 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 81 increasing their positions, 74 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 219 → 216 (-3)
36% less call options, than puts
Call options by funds: $1.09M | Put options by funds: $1.72M
88.12% less ownership
Funds ownership: 98.06% → 9.94% (-88%)
Holders
216
Holding in Top 10
1
Calls
$1.09M
Puts
$1.72M
Top Buyers
| 1 | +$45.7M | |
| 2 | +$43.1M | |
| 3 | +$13.4M | |
| 4 |
Renaissance Technologies
New York
|
+$10.4M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$10.2M |
Top Sellers
| 1 | -$83.9M | |
| 2 | -$18M | |
| 3 | -$17.7M | |
| 4 |
DP
DDD Partners
Bellevue,
Washington
|
-$11.8M |
| 5 |
Millennium Management
New York
|
-$9.97M |
